10-129536326-A-G
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The NM_002412.5(MGMT):āc.74A>Gā(p.Glu25Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000316 in 1,614,114 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_002412.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MGMT | NM_002412.5 | c.74A>G | p.Glu25Gly | missense_variant | 2/5 | ENST00000651593.1 | NP_002403.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MGMT | ENST00000651593.1 | c.74A>G | p.Glu25Gly | missense_variant | 2/5 | NM_002412.5 | ENSP00000498729 | P1 | ||
MGMT | ENST00000306010.8 | c.167A>G | p.Glu56Gly | missense_variant | 2/5 | 1 | ENSP00000302111 | |||
MGMT | ENST00000482547.1 | n.121A>G | non_coding_transcript_exon_variant | 2/2 | 2 | |||||
MGMT | ENST00000482653.1 | n.154A>G | non_coding_transcript_exon_variant | 2/3 | 3 |
Frequencies
GnomAD3 genomes AF: 0.0000329 AC: 5AN: 152154Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000955 AC: 24AN: 251422Hom.: 0 AF XY: 0.000103 AC XY: 14AN XY: 135874
GnomAD4 exome AF: 0.0000315 AC: 46AN: 1461842Hom.: 1 Cov.: 30 AF XY: 0.0000358 AC XY: 26AN XY: 727218
GnomAD4 genome AF: 0.0000328 AC: 5AN: 152272Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74456
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 18, 2022 | The c.167A>G (p.E56G) alteration is located in exon 2 (coding exon 2) of the MGMT gene. This alteration results from a A to G substitution at nucleotide position 167, causing the glutamic acid (E) at amino acid position 56 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at